(Q24293132)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764865%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Acceleration of alpha-synuclein aggregation by homologous peptides (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764865%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

GOA release 2020-03-11

identical protein binding

1 reference

GOA release 2020-03-11

1 reference

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764865%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Feng Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764865%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Hong-Tao Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764865%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Xiao-Jing Lin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764865%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jia-Hao Shi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764865%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Yan-Hong Shi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764865%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Li-Na Ji

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764865%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jun Hu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764865%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Dong-Hai Lin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764865%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Hong-Yu Hu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764865%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

English

0 references

publication date

2 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764865%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

number of pages

8

1 reference

inferred from page(s)

published in

FEBS Letters

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764865%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

580

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764865%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764865%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

3657-3664

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764865%20AND%20SRC:MED&resulttype=core&format=json

Amyloid diseases: abnormal protein aggregation in neurodegeneration

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

From Alzheimer to Huntington: why is a structural understanding so difficult?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

Alpha-synuclein and the Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

Molecular biology and pathogenesis of prion diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

The N-terminal region of non-A beta component of Alzheimer's disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

From conversion to aggregation: protofibril formation of the prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

A molecular model of Alzheimer amyloid beta-peptide fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

Biochemical characterization of the core structure of alpha-synuclein filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

Identification of the region of non-Abeta component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

Amino acid determinants of alpha-synuclein aggregation: putting together pieces of the puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

Inhibition of alpha-synuclein fibrillization by dopamine analogs via reaction with the amino groups of alpha-synuclein. Implication for dopaminergic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

An unstructured region is required by GAV homologue for the fibrillization of host proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

The most infectious prion protein particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

beta-sheet structure formation of proteins in solid state as revealed by circular dichroism spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

7 January 2021

The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease?

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

7 January 2021

[18] Quantification of β-sheet amyloid fibril structures with thioflavin T

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

7 January 2021

Reversion of prion protein conformational changes by synthetic b-sheet breaker peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

7 January 2021

Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

7 January 2021

Contribution of two conserved glycine residues to fibrillogenesis of the 106-126 prion protein fragment. Evidence that a soluble variant of the 106-126 peptide is neurotoxic

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

7 January 2021

Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a beta-sheet breaker peptide.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

7 January 2021

A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.050

7 January 2021